Global Radiopharmaceutical Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical.
The Radiopharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radiopharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical.
The Radiopharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radiopharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Radiopharmaceutical Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Radiopharmaceutical Sales Estimates and Forecasts (2019-2030)
1.3 Radiopharmaceutical Market by Type
1.3.1 Actinium-225
1.3.2 Lutetium-177
1.3.3 Radium-223
1.3.4 Holmium-166
1.3.5 Other
1.4 Global Radiopharmaceutical Market Size by Type
1.4.1 Global Radiopharmaceutical Market Size Overview by Type (2019-2030)
1.4.2 Global Radiopharmaceutical Historic Market Size Review by Type (2019-2024)
1.4.3 Global Radiopharmaceutical Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.2 Europe Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Radiopharmaceutical Revenue (2019-2024)
3.2 Global Top Players by Radiopharmaceutical Sales (2019-2024)
3.3 Global Top Players by Radiopharmaceutical Price (2019-2024)
3.4 Global Radiopharmaceutical Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Radiopharmaceutical Key Company Manufacturing Sites & Headquarters
3.6 Global Radiopharmaceutical Company, Product Type & Application
3.7 Global Radiopharmaceutical Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Radiopharmaceutical Market CR5 and HHI
3.8.2 Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
3.8.3 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
4 RADIOPHARMACEUTICAL REGIONAL STATUS AND OUTLOOK
4.1 Global Radiopharmaceutical Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Radiopharmaceutical Historic Market Size by Region
4.2.1 Global Radiopharmaceutical Sales in Volume by Region (2019-2024)
4.2.2 Global Radiopharmaceutical Sales in Value by Region (2019-2024)
4.2.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Radiopharmaceutical Forecasted Market Size by Region
4.3.1 Global Radiopharmaceutical Sales in Volume by Region (2025-2030)
4.3.2 Global Radiopharmaceutical Sales in Value by Region (2025-2030)
4.3.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 RADIOPHARMACEUTICAL BY APPLICATION
5.1 Radiopharmaceutical Market by Application
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Radiopharmaceutical Market Size by Application
5.2.1 Global Radiopharmaceutical Market Size Overview by Application (2019-2030)
5.2.2 Global Radiopharmaceutical Historic Market Size Review by Application (2019-2024)
5.2.3 Global Radiopharmaceutical Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.2 Europe Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Bracco Imaging
6.1.1 Bracco Imaging Comapny Information
6.1.2 Bracco Imaging Business Overview
6.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
6.1.5 Bracco Imaging Recent Developments
6.2 Bayer
6.2.1 Bayer Comapny Information
6.2.2 Bayer Business Overview
6.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Radiopharmaceutical Product Portfolio
6.2.5 Bayer Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Comapny Information
6.3.2 Mallinckrodt Business Overview
6.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
6.3.5 Mallinckrodt Recent Developments
6.4 Nordion
6.4.1 Nordion Comapny Information
6.4.2 Nordion Business Overview
6.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nordion Radiopharmaceutical Product Portfolio
6.4.5 Nordion Recent Developments
6.5 Triad Isotopes
6.5.1 Triad Isotopes Comapny Information
6.5.2 Triad Isotopes Business Overview
6.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
6.5.5 Triad Isotopes Recent Developments
6.6 Lantheus
6.6.1 Lantheus Comapny Information
6.6.2 Lantheus Business Overview
6.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lantheus Radiopharmaceutical Product Portfolio
6.6.5 Lantheus Recent Developments
6.7 IBA Group
6.7.1 IBA Group Comapny Information
6.7.2 IBA Group Business Overview
6.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.7.4 IBA Group Radiopharmaceutical Product Portfolio
6.7.5 IBA Group Recent Developments
6.8 GE Healthcare
6.8.1 GE Healthcare Comapny Information
6.8.2 GE Healthcare Business Overview
6.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
6.8.5 GE Healthcare Recent Developments
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Comapny Information
6.9.2 China Isotope & Radiation Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
6.9.5 China Isotope & Radiation Recent Developments
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Comapny Information
6.10.2 Jubilant Pharma Business Overview
6.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
6.10.5 Jubilant Pharma Recent Developments
6.11 Eli Lilly
6.11.1 Eli Lilly Comapny Information
6.11.2 Eli Lilly Business Overview
6.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
6.11.5 Eli Lilly Recent Developments
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Comapny Information
6.12.2 Advanced Accelerator Applications Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
6.12.5 Advanced Accelerator Applications Recent Developments
6.13 SIEMENS
6.13.1 SIEMENS Comapny Information
6.13.2 SIEMENS Business Overview
6.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.13.4 SIEMENS Radiopharmaceutical Product Portfolio
6.13.5 SIEMENS Recent Developments
6.14 Dongcheng
6.14.1 Dongcheng Comapny Information
6.14.2 Dongcheng Business Overview
6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Dongcheng Radiopharmaceutical Product Portfolio
6.14.5 Dongcheng Recent Developments
6.15 Navidea
6.15.1 Navidea Comapny Information
6.15.2 Navidea Business Overview
6.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Navidea Radiopharmaceutical Product Portfolio
6.15.5 Navidea Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Radiopharmaceutical Sales by Country
7.1.1 North America Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Radiopharmaceutical Sales by Country (2019-2024)
7.1.3 North America Radiopharmaceutical Sales Forecast by Country (2025-2030)
7.2 North America Radiopharmaceutical Market Size by Country
7.2.1 North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Radiopharmaceutical Market Size by Country (2019-2024)
7.2.3 North America Radiopharmaceutical Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Radiopharmaceutical Sales by Country
8.1.1 Europe Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Radiopharmaceutical Sales by Country (2019-2024)
8.1.3 Europe Radiopharmaceutical Sales Forecast by Country (2025-2030)
8.2 Europe Radiopharmaceutical Market Size by Country
8.2.1 Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Radiopharmaceutical Market Size by Country (2019-2024)
8.2.3 Europe Radiopharmaceutical Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Radiopharmaceutical Sales by Country
9.1.1 Asia-Pacific Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Radiopharmaceutical Sales by Country (2019-2024)
9.1.3 Asia-Pacific Radiopharmaceutical Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Radiopharmaceutical Market Size by Country
9.2.1 Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Radiopharmaceutical Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Radiopharmaceutical Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Radiopharmaceutical Sales by Country
10.1.1 Latin America Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Radiopharmaceutical Sales by Country (2019-2024)
10.1.3 Latin America Radiopharmaceutical Sales Forecast by Country (2025-2030)
10.2 Latin America Radiopharmaceutical Market Size by Country
10.2.1 Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Radiopharmaceutical Market Size by Country (2019-2024)
10.2.3 Latin America Radiopharmaceutical Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Radiopharmaceutical Sales by Country
11.1.1 Middle East and Africa Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Radiopharmaceutical Sales by Country (2019-2024)
11.1.3 Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Radiopharmaceutical Market Size by Country
11.2.1 Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Radiopharmaceutical Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Radiopharmaceutical Value Chain Analysis
12.1.1 Radiopharmaceutical Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Radiopharmaceutical Production Mode & Process
12.2 Radiopharmaceutical Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Radiopharmaceutical Distributors
12.2.3 Radiopharmaceutical Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Radiopharmaceutical Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Radiopharmaceutical Sales Estimates and Forecasts (2019-2030)
1.3 Radiopharmaceutical Market by Type
1.3.1 Actinium-225
1.3.2 Lutetium-177
1.3.3 Radium-223
1.3.4 Holmium-166
1.3.5 Other
1.4 Global Radiopharmaceutical Market Size by Type
1.4.1 Global Radiopharmaceutical Market Size Overview by Type (2019-2030)
1.4.2 Global Radiopharmaceutical Historic Market Size Review by Type (2019-2024)
1.4.3 Global Radiopharmaceutical Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.2 Europe Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Radiopharmaceutical Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Radiopharmaceutical Revenue (2019-2024)
3.2 Global Top Players by Radiopharmaceutical Sales (2019-2024)
3.3 Global Top Players by Radiopharmaceutical Price (2019-2024)
3.4 Global Radiopharmaceutical Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Radiopharmaceutical Key Company Manufacturing Sites & Headquarters
3.6 Global Radiopharmaceutical Company, Product Type & Application
3.7 Global Radiopharmaceutical Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Radiopharmaceutical Market CR5 and HHI
3.8.2 Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
3.8.3 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
4 RADIOPHARMACEUTICAL REGIONAL STATUS AND OUTLOOK
4.1 Global Radiopharmaceutical Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Radiopharmaceutical Historic Market Size by Region
4.2.1 Global Radiopharmaceutical Sales in Volume by Region (2019-2024)
4.2.2 Global Radiopharmaceutical Sales in Value by Region (2019-2024)
4.2.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Radiopharmaceutical Forecasted Market Size by Region
4.3.1 Global Radiopharmaceutical Sales in Volume by Region (2025-2030)
4.3.2 Global Radiopharmaceutical Sales in Value by Region (2025-2030)
4.3.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 RADIOPHARMACEUTICAL BY APPLICATION
5.1 Radiopharmaceutical Market by Application
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Radiopharmaceutical Market Size by Application
5.2.1 Global Radiopharmaceutical Market Size Overview by Application (2019-2030)
5.2.2 Global Radiopharmaceutical Historic Market Size Review by Application (2019-2024)
5.2.3 Global Radiopharmaceutical Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.2 Europe Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Radiopharmaceutical Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Bracco Imaging
6.1.1 Bracco Imaging Comapny Information
6.1.2 Bracco Imaging Business Overview
6.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
6.1.5 Bracco Imaging Recent Developments
6.2 Bayer
6.2.1 Bayer Comapny Information
6.2.2 Bayer Business Overview
6.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Radiopharmaceutical Product Portfolio
6.2.5 Bayer Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Comapny Information
6.3.2 Mallinckrodt Business Overview
6.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
6.3.5 Mallinckrodt Recent Developments
6.4 Nordion
6.4.1 Nordion Comapny Information
6.4.2 Nordion Business Overview
6.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nordion Radiopharmaceutical Product Portfolio
6.4.5 Nordion Recent Developments
6.5 Triad Isotopes
6.5.1 Triad Isotopes Comapny Information
6.5.2 Triad Isotopes Business Overview
6.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
6.5.5 Triad Isotopes Recent Developments
6.6 Lantheus
6.6.1 Lantheus Comapny Information
6.6.2 Lantheus Business Overview
6.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lantheus Radiopharmaceutical Product Portfolio
6.6.5 Lantheus Recent Developments
6.7 IBA Group
6.7.1 IBA Group Comapny Information
6.7.2 IBA Group Business Overview
6.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.7.4 IBA Group Radiopharmaceutical Product Portfolio
6.7.5 IBA Group Recent Developments
6.8 GE Healthcare
6.8.1 GE Healthcare Comapny Information
6.8.2 GE Healthcare Business Overview
6.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
6.8.5 GE Healthcare Recent Developments
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Comapny Information
6.9.2 China Isotope & Radiation Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
6.9.5 China Isotope & Radiation Recent Developments
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Comapny Information
6.10.2 Jubilant Pharma Business Overview
6.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
6.10.5 Jubilant Pharma Recent Developments
6.11 Eli Lilly
6.11.1 Eli Lilly Comapny Information
6.11.2 Eli Lilly Business Overview
6.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
6.11.5 Eli Lilly Recent Developments
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Comapny Information
6.12.2 Advanced Accelerator Applications Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
6.12.5 Advanced Accelerator Applications Recent Developments
6.13 SIEMENS
6.13.1 SIEMENS Comapny Information
6.13.2 SIEMENS Business Overview
6.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.13.4 SIEMENS Radiopharmaceutical Product Portfolio
6.13.5 SIEMENS Recent Developments
6.14 Dongcheng
6.14.1 Dongcheng Comapny Information
6.14.2 Dongcheng Business Overview
6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Dongcheng Radiopharmaceutical Product Portfolio
6.14.5 Dongcheng Recent Developments
6.15 Navidea
6.15.1 Navidea Comapny Information
6.15.2 Navidea Business Overview
6.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Navidea Radiopharmaceutical Product Portfolio
6.15.5 Navidea Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Radiopharmaceutical Sales by Country
7.1.1 North America Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Radiopharmaceutical Sales by Country (2019-2024)
7.1.3 North America Radiopharmaceutical Sales Forecast by Country (2025-2030)
7.2 North America Radiopharmaceutical Market Size by Country
7.2.1 North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Radiopharmaceutical Market Size by Country (2019-2024)
7.2.3 North America Radiopharmaceutical Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Radiopharmaceutical Sales by Country
8.1.1 Europe Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Radiopharmaceutical Sales by Country (2019-2024)
8.1.3 Europe Radiopharmaceutical Sales Forecast by Country (2025-2030)
8.2 Europe Radiopharmaceutical Market Size by Country
8.2.1 Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Radiopharmaceutical Market Size by Country (2019-2024)
8.2.3 Europe Radiopharmaceutical Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Radiopharmaceutical Sales by Country
9.1.1 Asia-Pacific Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Radiopharmaceutical Sales by Country (2019-2024)
9.1.3 Asia-Pacific Radiopharmaceutical Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Radiopharmaceutical Market Size by Country
9.2.1 Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Radiopharmaceutical Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Radiopharmaceutical Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Radiopharmaceutical Sales by Country
10.1.1 Latin America Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Radiopharmaceutical Sales by Country (2019-2024)
10.1.3 Latin America Radiopharmaceutical Sales Forecast by Country (2025-2030)
10.2 Latin America Radiopharmaceutical Market Size by Country
10.2.1 Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Radiopharmaceutical Market Size by Country (2019-2024)
10.2.3 Latin America Radiopharmaceutical Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Radiopharmaceutical Sales by Country
11.1.1 Middle East and Africa Radiopharmaceutical Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Radiopharmaceutical Sales by Country (2019-2024)
11.1.3 Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Radiopharmaceutical Market Size by Country
11.2.1 Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Radiopharmaceutical Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Radiopharmaceutical Value Chain Analysis
12.1.1 Radiopharmaceutical Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Radiopharmaceutical Production Mode & Process
12.2 Radiopharmaceutical Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Radiopharmaceutical Distributors
12.2.3 Radiopharmaceutical Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Actinium-225
Table 2. Major Company of Lutetium-177
Table 3. Major Company of Radium-223
Table 4. Major Company of Holmium-166
Table 5. Major Company of Other
Table 6. Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 8. Global Radiopharmaceutical Sales Market Share in Volume by Type (2019-2024)
Table 9. Global Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 10. Global Radiopharmaceutical Sales Market Share in Value by Type (2019-2024)
Table 11. Global Radiopharmaceutical Price by Type (2019-2024) & (USD/Dose)
Table 12. Global Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 13. Global Radiopharmaceutical Sales Market Share in Volume by Type (2025-2030)
Table 14. Global Radiopharmaceutical Sales by Type (2025-2030) & (US$ Million)
Table 15. Global Radiopharmaceutical Sales Market Share in Value by Type (2025-2030)
Table 16. Global Radiopharmaceutical Price by Type (2025-2030) & (USD/Dose)
Table 17. North America Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 18. North America Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 19. Europe Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 20. Europe Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 21. Asia-Pacific Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 22. Asia-Pacific Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 23. Latin America Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 24. Latin America Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 25. Middle East and Africa Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 26. Middle East and Africa Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 27. Radiopharmaceutical Industry Trends
Table 28. Radiopharmaceutical Industry Drivers
Table 29. Radiopharmaceutical Industry Opportunities and Challenges
Table 30. Radiopharmaceutical Industry Restraints
Table 31. Global Radiopharmaceutical Sales Revenue by Company (US$ Million) & (2019-2024)
Table 32. Global Radiopharmaceutical Revenue Market Share by Company (2019-2024)
Table 33. Global Radiopharmaceutical Sales by Company (2019-2024) & (M Doses)
Table 34. Global Radiopharmaceutical Sales Share by Company (2019-2024)
Table 35. Global Radiopharmaceutical Market Price by Company (2019-2024) & (USD/Dose)
Table 36. Global Radiopharmaceutical Industry Company Ranking, 2022 VS 2023 VS 2024
Table 37. Global Radiopharmaceutical Key Company Manufacturing Sites & Headquarters
Table 38. Global Radiopharmaceutical Company, Product Type & Application
Table 39. Global Radiopharmaceutical Company Commercialization Time
Table 40. Global Company Market Concentration Ratio (CR5 and HHI)
Table 41. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 42. Global Radiopharmaceutical Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 44. Global Radiopharmaceutical Sales Market Share in Volume by Region (2019-2024)
Table 45. Global Radiopharmaceutical Sales by Region (2019-2024) & (US$ Million)
Table 46. Global Radiopharmaceutical Sales Market Share in Value by Region (2019-2024)
Table 47. Global Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 48. Global Radiopharmaceutical Sales by Region (2025-2030) & (M Doses)
Table 49. Global Radiopharmaceutical Sales Market Share in Volume by Region (2025-2030)
Table 50. Global Radiopharmaceutical Sales by Region (2025-2030) & (US$ Million)
Table 51. Global Radiopharmaceutical Sales Market Share in Value by Region (2025-2030)
Table 52. Global Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2025-2030)
Table 53. Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 54. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 55. Global Radiopharmaceutical Sales Market Share in Volume by Application (2019-2024)
Table 56. Global Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 57. Global Radiopharmaceutical Sales Market Share in Value by Application (2019-2024)
Table 58. Global Radiopharmaceutical Price by Application (2019-2024) & (USD/Dose)
Table 59. Global Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 60. Global Radiopharmaceutical Sales Market Share in Volume by Application (2025-2030)
Table 61. Global Radiopharmaceutical Sales by Application (2025-2030) & (US$ Million)
Table 62. Global Radiopharmaceutical Sales Market Share in Value by Application (2025-2030)
Table 63. Global Radiopharmaceutical Price by Application (2025-2030) & (USD/Dose)
Table 64. North America Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 65. North America Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 66. Europe Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 67. Europe Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 68. Asia-Pacific Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 69. Asia-Pacific Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 70. Latin America Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 71. Latin America Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 72. Middle East and Africa Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 73. Middle East and Africa Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 74. Bracco Imaging Company Information
Table 75. Bracco Imaging Business Overview
Table 76. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 77. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 78. Bracco Imaging Recent Development
Table 79. Bayer Company Information
Table 80. Bayer Business Overview
Table 81. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. Bayer Radiopharmaceutical Product Portfolio
Table 83. Bayer Recent Development
Table 84. Mallinckrodt Company Information
Table 85. Mallinckrodt Business Overview
Table 86. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 88. Mallinckrodt Recent Development
Table 89. Nordion Company Information
Table 90. Nordion Business Overview
Table 91. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 92. Nordion Radiopharmaceutical Product Portfolio
Table 93. Nordion Recent Development
Table 94. Triad Isotopes Company Information
Table 95. Triad Isotopes Business Overview
Table 96. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 97. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 98. Triad Isotopes Recent Development
Table 99. Lantheus Company Information
Table 100. Lantheus Business Overview
Table 101. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 102. Lantheus Radiopharmaceutical Product Portfolio
Table 103. Lantheus Recent Development
Table 104. IBA Group Company Information
Table 105. IBA Group Business Overview
Table 106. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 107. IBA Group Radiopharmaceutical Product Portfolio
Table 108. IBA Group Recent Development
Table 109. GE Healthcare Company Information
Table 110. GE Healthcare Business Overview
Table 111. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 112. GE Healthcare Radiopharmaceutical Product Portfolio
Table 113. GE Healthcare Recent Development
Table 114. China Isotope & Radiation Company Information
Table 115. China Isotope & Radiation Business Overview
Table 116. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 117. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 118. China Isotope & Radiation Recent Development
Table 119. Jubilant Pharma Company Information
Table 120. Jubilant Pharma Business Overview
Table 121. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 122. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 123. Jubilant Pharma Recent Development
Table 124. Eli Lilly Company Information
Table 125. Eli Lilly Business Overview
Table 126. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 127. Eli Lilly Radiopharmaceutical Product Portfolio
Table 128. Eli Lilly Recent Development
Table 129. Advanced Accelerator Applications Company Information
Table 130. Advanced Accelerator Applications Business Overview
Table 131. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 132. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 133. Advanced Accelerator Applications Recent Development
Table 134. SIEMENS Company Information
Table 135. SIEMENS Business Overview
Table 136. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 137. SIEMENS Radiopharmaceutical Product Portfolio
Table 138. SIEMENS Recent Development
Table 139. Dongcheng Company Information
Table 140. Dongcheng Business Overview
Table 141. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 142. Dongcheng Radiopharmaceutical Product Portfolio
Table 143. Dongcheng Recent Development
Table 144. Navidea Company Information
Table 145. Navidea Business Overview
Table 146. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 147. Navidea Radiopharmaceutical Product Portfolio
Table 148. Navidea Recent Development
Table 149. North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 150. North America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 151. North America Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 152. North America Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 153. North America Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 154. North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 155. North America Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 156. North America Radiopharmaceutical Market Share by Country (2019-2024)
Table 157. North America Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 158. North America Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 159. Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 160. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 161. Europe Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 162. Europe Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 163. Europe Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 164. Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 165. Europe Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 166. Europe Radiopharmaceutical Market Share by Country (2019-2024)
Table 167. Europe Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 168. Europe Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 169. Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 170. Asia-Pacific Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 171. Asia-Pacific Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 172. Asia-Pacific Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 173. Asia-Pacific Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 174. Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 175. Asia-Pacific Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 176. Asia-Pacific Radiopharmaceutical Market Share by Country (2019-2024)
Table 177. Asia-Pacific Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 178. Asia-Pacific Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 179. Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 180. Latin America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 181. Latin America Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 182. Latin America Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 183. Latin America Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 184. Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 185. Latin America Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 186. Latin America Radiopharmaceutical Market Share by Country (2019-2024)
Table 187. Latin America Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 188. Latin America Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 189. Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 190. Middle East and Africa Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 191. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 192. Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 193. Middle East and Africa Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 194. Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 195. Middle East and Africa Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 196. Middle East and Africa Radiopharmaceutical Market Share by Country (2019-2024)
Table 197. Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 198. Middle East and Africa Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 199. Key Raw Materials
Table 200. Raw Materials Key Suppliers
Table 201. Radiopharmaceutical Distributors List
Table 202. Radiopharmaceutical Customers List
Table 203. Research Programs/Design for This Report
Table 204. Authors List of This Report
Table 205. Secondary Sources
Table 206. Primary Sources
Table 1. Major Company of Actinium-225
Table 2. Major Company of Lutetium-177
Table 3. Major Company of Radium-223
Table 4. Major Company of Holmium-166
Table 5. Major Company of Other
Table 6. Global Radiopharmaceutical Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 8. Global Radiopharmaceutical Sales Market Share in Volume by Type (2019-2024)
Table 9. Global Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 10. Global Radiopharmaceutical Sales Market Share in Value by Type (2019-2024)
Table 11. Global Radiopharmaceutical Price by Type (2019-2024) & (USD/Dose)
Table 12. Global Radiopharmaceutical Sales by Type (2025-2030) & (M Doses)
Table 13. Global Radiopharmaceutical Sales Market Share in Volume by Type (2025-2030)
Table 14. Global Radiopharmaceutical Sales by Type (2025-2030) & (US$ Million)
Table 15. Global Radiopharmaceutical Sales Market Share in Value by Type (2025-2030)
Table 16. Global Radiopharmaceutical Price by Type (2025-2030) & (USD/Dose)
Table 17. North America Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 18. North America Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 19. Europe Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 20. Europe Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 21. Asia-Pacific Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 22. Asia-Pacific Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 23. Latin America Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 24. Latin America Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 25. Middle East and Africa Radiopharmaceutical Sales by Type (2019-2024) & (M Doses)
Table 26. Middle East and Africa Radiopharmaceutical Sales by Type (2019-2024) & (US$ Million)
Table 27. Radiopharmaceutical Industry Trends
Table 28. Radiopharmaceutical Industry Drivers
Table 29. Radiopharmaceutical Industry Opportunities and Challenges
Table 30. Radiopharmaceutical Industry Restraints
Table 31. Global Radiopharmaceutical Sales Revenue by Company (US$ Million) & (2019-2024)
Table 32. Global Radiopharmaceutical Revenue Market Share by Company (2019-2024)
Table 33. Global Radiopharmaceutical Sales by Company (2019-2024) & (M Doses)
Table 34. Global Radiopharmaceutical Sales Share by Company (2019-2024)
Table 35. Global Radiopharmaceutical Market Price by Company (2019-2024) & (USD/Dose)
Table 36. Global Radiopharmaceutical Industry Company Ranking, 2022 VS 2023 VS 2024
Table 37. Global Radiopharmaceutical Key Company Manufacturing Sites & Headquarters
Table 38. Global Radiopharmaceutical Company, Product Type & Application
Table 39. Global Radiopharmaceutical Company Commercialization Time
Table 40. Global Company Market Concentration Ratio (CR5 and HHI)
Table 41. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 42. Global Radiopharmaceutical Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 44. Global Radiopharmaceutical Sales Market Share in Volume by Region (2019-2024)
Table 45. Global Radiopharmaceutical Sales by Region (2019-2024) & (US$ Million)
Table 46. Global Radiopharmaceutical Sales Market Share in Value by Region (2019-2024)
Table 47. Global Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 48. Global Radiopharmaceutical Sales by Region (2025-2030) & (M Doses)
Table 49. Global Radiopharmaceutical Sales Market Share in Volume by Region (2025-2030)
Table 50. Global Radiopharmaceutical Sales by Region (2025-2030) & (US$ Million)
Table 51. Global Radiopharmaceutical Sales Market Share in Value by Region (2025-2030)
Table 52. Global Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2025-2030)
Table 53. Global Radiopharmaceutical Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 54. Global Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 55. Global Radiopharmaceutical Sales Market Share in Volume by Application (2019-2024)
Table 56. Global Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 57. Global Radiopharmaceutical Sales Market Share in Value by Application (2019-2024)
Table 58. Global Radiopharmaceutical Price by Application (2019-2024) & (USD/Dose)
Table 59. Global Radiopharmaceutical Sales by Application (2025-2030) & (M Doses)
Table 60. Global Radiopharmaceutical Sales Market Share in Volume by Application (2025-2030)
Table 61. Global Radiopharmaceutical Sales by Application (2025-2030) & (US$ Million)
Table 62. Global Radiopharmaceutical Sales Market Share in Value by Application (2025-2030)
Table 63. Global Radiopharmaceutical Price by Application (2025-2030) & (USD/Dose)
Table 64. North America Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 65. North America Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 66. Europe Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 67. Europe Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 68. Asia-Pacific Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 69. Asia-Pacific Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 70. Latin America Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 71. Latin America Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 72. Middle East and Africa Radiopharmaceutical Sales by Application (2019-2024) & (M Doses)
Table 73. Middle East and Africa Radiopharmaceutical Sales by Application (2019-2024) & (US$ Million)
Table 74. Bracco Imaging Company Information
Table 75. Bracco Imaging Business Overview
Table 76. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 77. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 78. Bracco Imaging Recent Development
Table 79. Bayer Company Information
Table 80. Bayer Business Overview
Table 81. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. Bayer Radiopharmaceutical Product Portfolio
Table 83. Bayer Recent Development
Table 84. Mallinckrodt Company Information
Table 85. Mallinckrodt Business Overview
Table 86. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 88. Mallinckrodt Recent Development
Table 89. Nordion Company Information
Table 90. Nordion Business Overview
Table 91. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 92. Nordion Radiopharmaceutical Product Portfolio
Table 93. Nordion Recent Development
Table 94. Triad Isotopes Company Information
Table 95. Triad Isotopes Business Overview
Table 96. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 97. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 98. Triad Isotopes Recent Development
Table 99. Lantheus Company Information
Table 100. Lantheus Business Overview
Table 101. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 102. Lantheus Radiopharmaceutical Product Portfolio
Table 103. Lantheus Recent Development
Table 104. IBA Group Company Information
Table 105. IBA Group Business Overview
Table 106. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 107. IBA Group Radiopharmaceutical Product Portfolio
Table 108. IBA Group Recent Development
Table 109. GE Healthcare Company Information
Table 110. GE Healthcare Business Overview
Table 111. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 112. GE Healthcare Radiopharmaceutical Product Portfolio
Table 113. GE Healthcare Recent Development
Table 114. China Isotope & Radiation Company Information
Table 115. China Isotope & Radiation Business Overview
Table 116. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 117. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 118. China Isotope & Radiation Recent Development
Table 119. Jubilant Pharma Company Information
Table 120. Jubilant Pharma Business Overview
Table 121. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 122. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 123. Jubilant Pharma Recent Development
Table 124. Eli Lilly Company Information
Table 125. Eli Lilly Business Overview
Table 126. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 127. Eli Lilly Radiopharmaceutical Product Portfolio
Table 128. Eli Lilly Recent Development
Table 129. Advanced Accelerator Applications Company Information
Table 130. Advanced Accelerator Applications Business Overview
Table 131. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 132. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 133. Advanced Accelerator Applications Recent Development
Table 134. SIEMENS Company Information
Table 135. SIEMENS Business Overview
Table 136. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 137. SIEMENS Radiopharmaceutical Product Portfolio
Table 138. SIEMENS Recent Development
Table 139. Dongcheng Company Information
Table 140. Dongcheng Business Overview
Table 141. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 142. Dongcheng Radiopharmaceutical Product Portfolio
Table 143. Dongcheng Recent Development
Table 144. Navidea Company Information
Table 145. Navidea Business Overview
Table 146. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 147. Navidea Radiopharmaceutical Product Portfolio
Table 148. Navidea Recent Development
Table 149. North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 150. North America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 151. North America Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 152. North America Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 153. North America Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 154. North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 155. North America Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 156. North America Radiopharmaceutical Market Share by Country (2019-2024)
Table 157. North America Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 158. North America Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 159. Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 160. Europe Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 161. Europe Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 162. Europe Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 163. Europe Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 164. Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 165. Europe Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 166. Europe Radiopharmaceutical Market Share by Country (2019-2024)
Table 167. Europe Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 168. Europe Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 169. Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 170. Asia-Pacific Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 171. Asia-Pacific Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 172. Asia-Pacific Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 173. Asia-Pacific Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 174. Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 175. Asia-Pacific Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 176. Asia-Pacific Radiopharmaceutical Market Share by Country (2019-2024)
Table 177. Asia-Pacific Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 178. Asia-Pacific Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 179. Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 180. Latin America Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 181. Latin America Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 182. Latin America Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 183. Latin America Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 184. Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 185. Latin America Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 186. Latin America Radiopharmaceutical Market Share by Country (2019-2024)
Table 187. Latin America Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 188. Latin America Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 189. Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 190. Middle East and Africa Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 191. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 192. Middle East and Africa Radiopharmaceutical Sales Forecast by Country (2025-2030) & (M Doses)
Table 193. Middle East and Africa Radiopharmaceutical Sales Market Share Forecast by Country (2025-2030)
Table 194. Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 195. Middle East and Africa Radiopharmaceutical Market Size by Country (2019-2024) & (US$ Million)
Table 196. Middle East and Africa Radiopharmaceutical Market Share by Country (2019-2024)
Table 197. Middle East and Africa Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 198. Middle East and Africa Radiopharmaceutical Market Share Forecast by Country (2025-2030)
Table 199. Key Raw Materials
Table 200. Raw Materials Key Suppliers
Table 201. Radiopharmaceutical Distributors List
Table 202. Radiopharmaceutical Customers List
Table 203. Research Programs/Design for This Report
Table 204. Authors List of This Report
Table 205. Secondary Sources
Table 206. Primary Sources
LIST OF FIGURES
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Radiopharmaceutical Market Size (2019-2030) & (US$ Million)
Figure 4. Global Radiopharmaceutical Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Actinium-225
Figure 6. Global Actinium-225 Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Lutetium-177
Figure 8. Global Lutetium-177 Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Product Picture of Radium-223
Figure 10. Global Radium-223 Sales YoY Growth (2019-2030) & (M Doses)
Figure 11. Product Picture of Holmium-166
Figure 12. Global Holmium-166 Sales YoY Growth (2019-2030) & (M Doses)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales YoY Growth (2019-2030) & (M Doses)
Figure 15. Global Radiopharmaceutical Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Radiopharmaceutical Market Share by Type 2023 VS 2030
Figure 17. North America Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 18. North America Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 19. Europe Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 20. Europe Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 21. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 22. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 23. Latin America Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 24. Latin America Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 25. Middle East and Africa Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 26. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 27. Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 29. Product Picture of Oncology
Figure 30. Global Oncology Sales YoY Growth (2019-2030) & (M Doses)
Figure 31. Product Picture of Cardiology
Figure 32. Global Cardiology Sales YoY Growth (2019-2030) & (M Doses)
Figure 33. Product Picture of Other
Figure 34. Global Other Sales YoY Growth
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Radiopharmaceutical Market Size (2019-2030) & (US$ Million)
Figure 4. Global Radiopharmaceutical Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Actinium-225
Figure 6. Global Actinium-225 Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Lutetium-177
Figure 8. Global Lutetium-177 Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Product Picture of Radium-223
Figure 10. Global Radium-223 Sales YoY Growth (2019-2030) & (M Doses)
Figure 11. Product Picture of Holmium-166
Figure 12. Global Holmium-166 Sales YoY Growth (2019-2030) & (M Doses)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales YoY Growth (2019-2030) & (M Doses)
Figure 15. Global Radiopharmaceutical Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Radiopharmaceutical Market Share by Type 2023 VS 2030
Figure 17. North America Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 18. North America Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 19. Europe Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 20. Europe Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 21. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 22. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 23. Latin America Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 24. Latin America Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 25. Middle East and Africa Radiopharmaceutical Sales Market Share in Volume by Type in 2023
Figure 26. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Type in 2023
Figure 27. Global Top 5 and 10 Radiopharmaceutical Players Market Share by Revenue in 2023
Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 29. Product Picture of Oncology
Figure 30. Global Oncology Sales YoY Growth (2019-2030) & (M Doses)
Figure 31. Product Picture of Cardiology
Figure 32. Global Cardiology Sales YoY Growth (2019-2030) & (M Doses)
Figure 33. Product Picture of Other
Figure 34. Global Other Sales YoY Growth
